|
Real-time Estimate
Tradegate
06:53:05 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 4.221 EUR | -13.68% |
|
+18.12% | -25.80% |
| 07-24 | Adocia provides a second-quarter update, Stifel still rates it a buy |  |
| 07-23 | Adocia SA Reports Unaudited Revenue Results for Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 96.57M | - | ||||
| 72.21B | |||||
| 63.98B | |||||
| 28.53B | - | ||||
| 25.07B | |||||
| 28.42B | - |
- Stock Market
- Stocks
- ADOC Stock
- 0QAI Stock
- Charts Adocia
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
